Hair Cosmetic Alterations

    Ramón Grimalt
    Image of study
    TLDR The document concludes that individualized treatments for hair issues are effective, certain hair changes can indicate neurocutaneous diseases, specific lotions improve skin health, laser hair removal works but needs more study on long-term effects, men's cosmetics are diverse, peeling is effective but can have side effects, and facial pigmentation is often due to overactive skin cells.
    The document from 1998 discusses various topics related to hair and skin care in dermatocosmetology. It covers the treatment of hirsutism, which should be tailored to the individual's hormonal imbalance, with medications such as antiandrogens (Cyproteroneacetate, Spironolactone, Ketokonazole, and Flutamide) and 5α-Reductase inhibitors (Finasteride). Cosmetic measures may support medical treatment. Acquired hair kinking conditions, such as circle hairs, acquired pili torti, corkscrew hair, whisker hair, and diffuse partial woolly hair, are described with their characteristics and potential causes. The document also reports on hair shaft alterations in neurocutaneous diseases, suggesting that these alterations could serve as clinical markers and provide insight into disease pathogenesis. A study on the effect of ceramides-containing lotions on skin barrier function and hydration is summarized, showing that lotions with a mixture of ceramides, cholesterol, and free fatty acids can accelerate barrier recovery and improve skin hydration. Hair cosmetic alterations from external factors are classified into four grades of cuticular hair damage. The efficacy of laser epilation is confirmed, although the permanence of results requires further research. Men's cosmetics are briefly mentioned, covering a range of products from perfumery to hair and skin care. Peeling treatments are discussed as effective and adaptable, with a cautionary note on the potential for adverse effects such as dyspigmentation. Lastly, facial hyperpigmentations are mentioned, with a focus on epidermal melanoses caused by hyperactive melanocytes.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 25 results

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  53 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Spironolactone or bicalutamide prescription

      in Treatment  4 upvotes 1 year ago
      The conversation is about someone seeking a doctor in the EU who prescribes spironolactone or bicalutamide for female pattern hair loss, as they are having difficulty finding treatment options beyond Minoxidil in Austria. They are asking for recommendations and are open to direct messages for assistance.

      community I am having Success with RU58841 and 1mm Derma Roller

      in Microneedling  19 upvotes 2 years ago
      A user reported success with RU58841 and a 1mm derma roller for hair regrowth, noting significant improvement in hair density and reduced scalp visibility. They also mentioned using minoxidil and black castor oil in the past, with mixed results.

      community DHT levels after 4 weeks of Fina and 8 weeks of Fina + 4 weeks of Duta

      in Update  35 upvotes 5 years ago
      The user reported early stage diffuse hair thinning and increased DHT levels after 4 weeks on Finasteride and 8 weeks on Finasteride plus 4 weeks on Dutasteride, despite the medications being authentic and stored properly. They are considering increasing their Dutasteride dosage due to the lack of side effects and are unsure if the treatment is helping their hair.

      community Coegin Pharma to release Follicopeptide (FOL005) by Q2 2025

      in Treatment  118 upvotes 3 months ago
      Follicopeptide (FOL005) by Coegin Pharma will launch as a cosmetic hair growth treatment by Q2 2025, showing similar efficacy to finasteride. Users discuss the benefits and skepticism of releasing hair loss treatments as cosmetics rather than drugs.

    Similar Research

    5 / 1000+ results